These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4595073)

  • 21. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effect of a beta receptor blockader, oxprenolol, in hypertension--its relationship with renin-aldosterone activities].
    Kunida H; Hatake S; Okamoto M
    Horumon To Rinsho; 1974 Sep; 22(9):1067-75. PubMed ID: 4609642
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 26. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once daily beta-blocker in hypertension--oxprenolol slow-release.
    Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
    J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
    Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol.
    Jones DH; Daniel J; Hamilton CA; Reid JL
    Br J Clin Pharmacol; 1980 Jan; 9(1):27-31. PubMed ID: 7356889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of beta adrenergic block on arterial hypertension and the electrocardiographic signs of myocardium damage].
    Bisteni A
    Prensa Med Mex; 1977; 42(11-12):516-21. PubMed ID: 614548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
    Gerc V; Numić N
    Med Arh; 1980; 34(1):51-9. PubMed ID: 7007752
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of the hypotensive effect of a combination of oxprenolol-chlortalidone with single and fractionated administration].
    Rubegni M; Provvedi D; Bandinelli C; Bellini PG; De Mauro G
    Boll Soc Ital Cardiol; 1976; 21(10):1853-8. PubMed ID: 1031614
    [No Abstract]   [Full Text] [Related]  

  • 36. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
    Forrest WA
    Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term experiences with an antihypertensive combination].
    Hilgert A; Horch G
    Med Welt; 1982 Jul; 33(29-30):1067-70. PubMed ID: 6750310
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H; Schmieder R; Langewitz W; Neus J; Wagner O; von Eiff AW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxprenolol hydrochloride: a long-term study of efficacy, safety, and tolerability.
    Tarpley EL
    Pharmacotherapy; 1982; 2(5):281-4. PubMed ID: 6820501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of excited psychoses using a beta receptor blockader (oxprenolol) in high dosage].
    Volk W; Bier W; Braun JP; Grüter W; Spiegelberg U
    Nervenarzt; 1972 Sep; 43(9):491-2. PubMed ID: 5076477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.